Last reviewed · How we verify
NCT05738655
Effectiveness of Pumpkin Seed Extract on Improving Blood Sugar Level in Subhealth Subjects
NA trial testing Pumpkin seed extract (Low dose) in Diabetes in 60 participants. Status unknown.
30 September 2024
Quick facts
| Lead sponsor | Greenyn Biotechnology Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 60 |
| Start date | 1 March 2023 |
| Primary completion | 30 September 2024 |
| Estimated completion | 31 October 2024 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Pumpkin seed extract (Low dose)
- Pumpkin seed extract (High dose)
- Placebo
Conditions studied
- Diabetes — all drugs for Diabetes →
- Metabolic Disease — all drugs for Metabolic Disease →
Sponsor
Greenyn Biotechnology Co., Ltd.
Who can join
Adults 20 to 75, any sex, with Diabetes or Metabolic Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized, double-blind, placebo-controlled, and parallel clinical study aims to investigate the effectivness of a pumpkin seed extract on blood sugar management in subhealth people.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05738655
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes
Currently open trials in the same condition.
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07479134 — Production of Stem Cells for the Generation of Pancreatic Cells · NA · recruiting
- NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
- NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
- NCT07417865 — ECHO Diabetes FQHC · recruiting
Other Greenyn Biotechnology Co., Ltd. trials
Trials by the same sponsor.
- NCT05728918 — Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People · NA · completed
- NCT05542160 — Effectiveness of IRK-19® on Body Weight Control · NA · completed
- NCT05309161 — Efficacy Testing of Crassocephalum Rabens Extract Capsules · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05738655 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Greenyn Biotechnology Co., Ltd.
- Last refreshed: 23 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05738655.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing